Kave Shams

524 total citations
27 papers, 295 citations indexed

About

Kave Shams is a scholar working on Immunology, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kave Shams has authored 27 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Dermatology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kave Shams's work include Psoriasis: Treatment and Pathogenesis (8 papers), Dermatology and Skin Diseases (5 papers) and Occupational and environmental lung diseases (5 papers). Kave Shams is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (8 papers), Dermatology and Skin Diseases (5 papers) and Occupational and environmental lung diseases (5 papers). Kave Shams collaborates with scholars based in United Kingdom, Spain and Switzerland. Kave Shams's co-authors include D. J. C. Grindlay, Hywel C Williams, G.M. Kavanagh, Gerard J. Graham, Clive S. McKimmie, A. David Burden, Mariola Kurowska‐Stolarska, E. Rodríguez Becerra, Francisco Rodríguez Panadero and Jaume Ferrer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Kave Shams

23 papers receiving 287 citations

Peers

Kave Shams
Dawn M. Cleaver United States
P. Berbis France
J L Verret France
Aimee C. Smidt United States
R. Saltzman United States
M.C.G. van Praag Netherlands
Anand Rajpara United States
Sabra Sullivan United States
Dawn M. Cleaver United States
Kave Shams
Citations per year, relative to Kave Shams Kave Shams (= 1×) peers Dawn M. Cleaver

Countries citing papers authored by Kave Shams

Since Specialization
Citations

This map shows the geographic impact of Kave Shams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kave Shams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kave Shams more than expected).

Fields of papers citing papers by Kave Shams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kave Shams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kave Shams. The network helps show where Kave Shams may publish in the future.

Co-authorship network of co-authors of Kave Shams

This figure shows the co-authorship network connecting the top 25 collaborators of Kave Shams. A scholar is included among the top collaborators of Kave Shams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kave Shams. Kave Shams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rademaker, Marius, Vimal H. Prajapati, Dédée F. Murrell, et al.. (2025). Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up). British Journal of Dermatology. 193(6). 1101–1111. 1 indexed citations
3.
Harrison, Stephanie R, Fiona Campbell, Hannah Bennett, et al.. (2024). High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study. British Journal of Dermatology. 191(6). 1018–1020. 1 indexed citations
4.
Shams, Kave, et al.. (2023). P97 Risankizumab real-world effectiveness in UK clinical practice: results from the BADBIR registry. British Journal of Dermatology. 188(Supplement_4). 1 indexed citations
5.
Lefteri, Daniella, Steven R. Bryden, Marieke Pingen, et al.. (2022). Mosquito  saliva enhances virus infection through sialokinin-dependent vascular leakage. Proceedings of the National Academy of Sciences. 119(24). e2114309119–e2114309119. 29 indexed citations
6.
Ajjan, Ramzi, E. Hensor, Francesco Del Galdo, et al.. (2022). Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomised controlled trial. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 15 indexed citations
8.
Freeston, Jane, Andrew Barr, Christian P. Selinger, et al.. (2020). Improving patient care through a collaborative effort in the Leeds Combined Psoriatic Service: an effective provision of multi-specialty input. Lara D. Veeken. 60(1). 467–470. 3 indexed citations
9.
Bryden, Steven R., Marieke Pingen, Daniella Lefteri, et al.. (2020). Pan-viral protection against arboviruses by activating skin macrophages at the inoculation site. Science Translational Medicine. 12(527). 25 indexed citations
11.
Shams, Kave, et al.. (2017). MicroRNA-146 and cell trauma down-regulate expression of the psoriasis-associated atypical chemokine receptor ACKR2. Journal of Biological Chemistry. 293(8). 3003–3012. 23 indexed citations
12.
Shams, Kave, Gillian Wilson, Ellen H. van den Bogaard, et al.. (2016). Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2. Journal of Investigative Dermatology. 137(1). 85–94. 26 indexed citations
13.
Healy, Eugene, Sara Brown, Sinéad Langan, et al.. (2015). Identification of translational dermatology research priorities in the U.K.: results of an electronic Delphi exercise. British Journal of Dermatology. 173(5). 1191–1198. 9 indexed citations
14.
Savage, L., et al.. (2014). Management of morphoea: results of a national survey of U.K. clinicians. British Journal of Dermatology. 171(5). 1243–1245. 4 indexed citations
15.
Baldwin, Helen, David Burden, Iain B. McInnes, et al.. (2012). Elevated Expression of the Chemokine-Scavenging Receptor D6 Is Associated with Impaired Lesion Development in Psoriasis. American Journal Of Pathology. 181(4). 1158–1164. 37 indexed citations
16.
Shams, Kave & A. David Burden. (2012). Updates from the Sixth International Congress ‘Psoriasis: from Gene to Clinic’, the Queen Elizabeth II Conference Centre, London, U.K., 1-3 December 2011. British Journal of Dermatology. 167(4). 757–761. 2 indexed citations
17.
Shams, Kave, D. J. C. Grindlay, & Hywel C Williams. (2011). What’s new in atopic eczema? An analysis of systematic reviews published in 2009-2010. Clinical and Experimental Dermatology. 36(6). 573–578. 42 indexed citations
18.
Shams, Kave, et al.. (2005). Normativa sobre el asbesto y sus enfermedades pleuropulmonares (Grupo de Trabajo EROL-SEPAR). Archivos de Bronconeumología. 41(3). 153–168. 4 indexed citations
19.
Shams, Kave, et al.. (2005). Guidelines on Asbestos-Related Pleuropulmonary Disease. Archivos de Bronconeumología. 41(3). 153–168. 14 indexed citations
20.
Kavanagh, G.M., et al.. (2004). BOTOXR delivery by iontophoresis. British Journal of Dermatology. 151(5). 1093–1095. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026